Rohlen Douglas 4
4 · ENTELLUS MEDICAL INC · Filed Mar 1, 2018
Insider Transaction Report
Form 4
Rohlen Douglas
Director
Transactions
- Disposition to Issuer
Common Stock, $0.001 par value
2018-02-28$24.00/sh−20,299$487,176→ 0 total(indirect: By Trust) - Disposition to Issuer
Common Stock, $0.001 par value
2018-02-28$24.00/sh−4,684$112,416→ 0 total(indirect: By Trust) - Disposition to Issuer
Stock Option (right to buy)
2018-02-28$6.33/sh−7,500$47,475→ 0 totalExercise: $17.67Exp: 2027-07-14→ Common Stock (7,500 underlying) - Disposition to Issuer
Common Stock, $0.001 par value
2018-02-28$24.00/sh−9,217$221,208→ 0 total - Disposition to Issuer
Common Stock, $0.001 par value
2018-02-28$24.00/sh−6,834$164,016→ 0 total(indirect: By LLC)
Footnotes (2)
- [F1]Disposed of pursuant to an Agreement and Plan of Merger, dated December 7, 2017, between Entellus Medical, Inc., Stryker Corporation and Explorer Merger Sub Corp. in exchange for a cash payment of $24.00 per share.
- [F2]This option, which provided for vesting in 12 equal quarterly installments commencing on July 14, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.